Drug
Afm 13
Afm 13: highest development phase Phase 1, developed by Affimed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Affimed
Trials
| Drug | Phase | Indication |
|---|---|---|
| AFM 13 NCT01221571 | Phase 1 | Hodgkin Lymphoma |
Latest
No recent events.
Follow Afm 13 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.